Linvoseltamab is a bispecific antibody targeting BCMA (TNFRSF17) and CD3. Linvoseltamab is used in studies related to relapsed/refractory multiple myeloma (R/R MM).
Purity:
>99.0%
CAS Number:
[2408319-25-3]
* VAT and and shipping costs not included. Errors and price changes excepted